D-Pen-Dimer CAS 20902-45-8

Product Name:D-Pen-Dimer
CAS NO.:20902-45-8
Appearance:White powder
TNN specializes in food additives, pharmaceutical ingredients, Cosmetic Raw Materials, Fine Chemicals, etc. Please feel free to inquire if you have any needs.

Send Inquiry

Description

The TNN Development Limited is one of the most reliable manufacturers and suppliers of d-pen-dimer cas 20902-45-8 in China. Please feel free to wholesale customized d-pen-dimer cas 20902-45-8 at low price from our factory. If you have any enquiry about free sample and discount information, please feel free to email us.

Products Description

Product name	D-Pen-Dimer
CAS NO.	20902-45-8
Purity	＞98%
Alcohol	without alcohol
Packaging Type	PP bag /cardboard bucket
Material	pharmaceutical intermediates
Sheet Size	1kg/10kg/20kg/100kg
Prodcut Weight	1.2kg/12kg/23kg/115kg
Counts	1kg/bag 10kg/bucket 20kg/bucket 100kg/bucket
Certifications	ISO9001
Shelf life	24 month
MOQ	100 g

Functions

D-Pen-Dimer is an important pharmaceutical intermediate with unique biological activity and therapeutic value. This compound plays a crucial biochemical regulatory role in the body through its special disulfide bond in its molecular structure, and is mainly used for the treatment of genetic metabolic diseases.
From the perspective of its mechanism of action, the core value of this compound lies in its ability to participate in the dynamic balance of thiol disulfide bonds in the body. The disulfide bonds in its molecules can undergo exchange reactions with thiol containing compounds such as cysteine in the body, forming mixed disulfides. This characteristic enables it to effectively chelate excess copper ions in the body, promoting their excretion by forming stable copper complexes. At the same time, it can also undergo disulfide bond exchange with cysteine molecules, generating water-soluble mixed disulfides, thereby significantly increasing the solubility of cysteine.
In clinical applications, D-penicillamine disulfide exhibits unique therapeutic value. As an important component of the treatment plan for Wilson's disease, it effectively helps patients eliminate excess copper ions accumulated in the body and prevent organ damage through its specific copper chelation ability. In the treatment of cystinuria, this compound significantly reduces the risk of urinary stone formation by converting insoluble cysteine into soluble complexes, providing patients with an effective treatment plan.
In addition, this disulfide bond exchange mechanism also demonstrates potential application value in the field of heavy metal detoxification. Its specific metal ion binding properties make it a potential candidate drug for treating specific heavy metal poisoning, demonstrating its diverse application prospects in the pharmaceutical field.